T. Fladvad

Most-cited papers

1. Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients

   P. Klepstad, T. Fladvad, F. Skorpen, K. Bjordal +12 more

   2011Pain203 citations

   Semantic Scholar

   Save

2. Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.

   E. A. Laugsand, T. Fladvad, F. Skorpen, M. Maltoni +3 more

   2011European Journal of Cancer88 citations

   Semantic Scholar

   Save

3. Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory element‐binding protein 1

   S. Schønberg, Anne Gøril Lundemo, T. Fladvad, K. Holmgren +6 more

   2006The FEBS Journal84 citations Open access

   Semantic Scholar

   Save

4. P-selectin genotype is associated with the development of cancer cachexia

   B. Tan, T. Fladvad, Theodore P. Braun, A. Vigano +11 more

   2012EMBO Molecular Medicine48 citations Open access

   Semantic Scholar

   Save

5. Multiple Loci Modulate Opioid Therapy Response for Cancer Pain

   A. Galvan, F. Skorpen, P. Klepstad, A. K. Knudsen +7 more

   2011Clinical Cancer Research39 citations

   Semantic Scholar

   Save

6. Variability in UDP-glucuronosyltransferase genes and morphine metabolism: observations from a cross-sectional multicenter study in advanced cancer patients with pain

   T. Fladvad, P. Klepstad, M. Langaas, O. Dale +3 more

   2013Pharmacogenetics & Genomics18 citations

   Semantic Scholar

   Save

7. Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients

   T. Solheim, P. Fayers, T. Fladvad, B. Tan +6 more

   2012Journal of Cachexia, Sarcopenia and Muscle18 citations Open access

   Semantic Scholar

   Save

8. Genetic clustering of European cancer patients indicates that opioid-mediated pain relief is independent of ancestry

   A. Galvan, T. Fladvad, F. Skorpen, X. Gao +3 more

   2011The Pharmacogenomics Journal13 citations Open access

   Semantic Scholar

   Save

9. Lack of association between genetic variability and multiple pain-related outcomes in a large cohort of patients with advanced cancer: the European Pharmacogenetic Opioid Study (EPOS)

   T. Fladvad, P. Fayers, F. Skorpen, S. Kaasa +1 more

   2012BMJ Supportive & Palliative Care12 citations

   Semantic Scholar

   Save

10. Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients

    Ts Solheim, P. Fayers, T. Fladvad, B. Tan +6 more

    2011British Journal of Cancer12 citations Open access

    Semantic Scholar

    Save

11. The N-Terminally Truncated µ3 and µ3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene

    S. Andersen, Cecilie Báár, T. Fladvad, E. A. Laugsand +1 more

    2013PLoS ONE8 citations Open access

    Semantic Scholar

    Save

12. Pain treatment in patients with advanced cancer disease:the impact of genetic variability

    T. Fladvad

    20130 citations

    Semantic Scholar

    Save

13. A P-selectin polymophism is associated with the development of cancer cachexia: Results of a candidate gene association study

    B. Tan, T. Fladvad, V. Baracos, D. A. Christopher Deans +2 more

    20110 citations

    Semantic Scholar

    Save